Patients in chronic prednisone use in a Brazilian municipality: are potential adverse events being monitored?

Introduction: chronic use of corticosteroids can trigger several adverse effects with changes in glycemic, lipid, liver enzymes and electrolyte levels. Therefore, the the aim of the present study was to analyze if the patients on chronic prednisone use from the Brazilian Public Health System (PHS)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Virgínia M. Bolina, Thays S. Mendonça, Mariana L. Pereira, Caroline P. Domingueti, João P. Rodrigues, Tiago M. Reis, André Oliveira Baldoni
Formato: article
Lenguaje:EN
PT
Publicado: Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde 2020
Materias:
Acceso en línea:https://doaj.org/article/71de3191bf954d0894f974a752565640
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:71de3191bf954d0894f974a752565640
record_format dspace
spelling oai:doaj.org-article:71de3191bf954d0894f974a7525656402021-11-28T02:46:11ZPatients in chronic prednisone use in a Brazilian municipality: are potential adverse events being monitored?10.30968/rbfhss.2019.104.03432179-59242316-7750https://doaj.org/article/71de3191bf954d0894f974a7525656402020-03-01T00:00:00Zhttps://www.rbfhss.org.br/sbrafh/article/view/343https://doaj.org/toc/2179-5924https://doaj.org/toc/2316-7750 Introduction: chronic use of corticosteroids can trigger several adverse effects with changes in glycemic, lipid, liver enzymes and electrolyte levels. Therefore, the the aim of the present study was to analyze if the patients on chronic prednisone use from the Brazilian Public Health System (PHS) in a Midwestern municipality of the state of Minas Gerais were monitored for their adverse effects through laboratory tests. Methods: a longitudinal descriptive study was carried out with retrospective data from patients attended by the PHS of this city, and who have used prednisone chronically for three consecutive years, from 2014 to 2016. The frequency of patients who underwent tests to monitor adverse events from the chronic use of prednisone was verified through electronic records in the Integrated Health System (IHS). The following types of tests were analyzed: total serum calcium, urine calcium (24-hour urine), serum phosphate, alkaline phosphatase, fasting glucose, sodium (Na+), potassium (K+), and lipidogram (triglycerides, LDL, VLDL, HDL, and total cholesterol). Results: it was observed that fasting glucose and lipidogram were the tests that presented the highest number of annual records. However, for the other examined parameters, which are essential for the follow-up of patients in chronic use of corticosteroids, the non-monitoring index is greater than 80 %. Conclusions: the results revealed an inadequate frequency of laboratory monitoring of patients in chronic prednisone use, indicating the occurrence of prescriptions without the monitoring of possible adverse effects, which may constitute safety problems for patients. Virgínia M. BolinaThays S. MendonçaMariana L. PereiraCaroline P. DominguetiJoão P. RodriguesTiago M. ReisAndré Oliveira BaldoniSociedade Brasileira de Farmácia Hospitalar e Serviços de SaúdearticlePublic aspects of medicineRA1-1270Pharmacy and materia medicaRS1-441Therapeutics. PharmacologyRM1-950ENPTRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Vol 10, Iss 4 (2020)
institution DOAJ
collection DOAJ
language EN
PT
topic Public aspects of medicine
RA1-1270
Pharmacy and materia medica
RS1-441
Therapeutics. Pharmacology
RM1-950
spellingShingle Public aspects of medicine
RA1-1270
Pharmacy and materia medica
RS1-441
Therapeutics. Pharmacology
RM1-950
Virgínia M. Bolina
Thays S. Mendonça
Mariana L. Pereira
Caroline P. Domingueti
João P. Rodrigues
Tiago M. Reis
André Oliveira Baldoni
Patients in chronic prednisone use in a Brazilian municipality: are potential adverse events being monitored?
description Introduction: chronic use of corticosteroids can trigger several adverse effects with changes in glycemic, lipid, liver enzymes and electrolyte levels. Therefore, the the aim of the present study was to analyze if the patients on chronic prednisone use from the Brazilian Public Health System (PHS) in a Midwestern municipality of the state of Minas Gerais were monitored for their adverse effects through laboratory tests. Methods: a longitudinal descriptive study was carried out with retrospective data from patients attended by the PHS of this city, and who have used prednisone chronically for three consecutive years, from 2014 to 2016. The frequency of patients who underwent tests to monitor adverse events from the chronic use of prednisone was verified through electronic records in the Integrated Health System (IHS). The following types of tests were analyzed: total serum calcium, urine calcium (24-hour urine), serum phosphate, alkaline phosphatase, fasting glucose, sodium (Na+), potassium (K+), and lipidogram (triglycerides, LDL, VLDL, HDL, and total cholesterol). Results: it was observed that fasting glucose and lipidogram were the tests that presented the highest number of annual records. However, for the other examined parameters, which are essential for the follow-up of patients in chronic use of corticosteroids, the non-monitoring index is greater than 80 %. Conclusions: the results revealed an inadequate frequency of laboratory monitoring of patients in chronic prednisone use, indicating the occurrence of prescriptions without the monitoring of possible adverse effects, which may constitute safety problems for patients.
format article
author Virgínia M. Bolina
Thays S. Mendonça
Mariana L. Pereira
Caroline P. Domingueti
João P. Rodrigues
Tiago M. Reis
André Oliveira Baldoni
author_facet Virgínia M. Bolina
Thays S. Mendonça
Mariana L. Pereira
Caroline P. Domingueti
João P. Rodrigues
Tiago M. Reis
André Oliveira Baldoni
author_sort Virgínia M. Bolina
title Patients in chronic prednisone use in a Brazilian municipality: are potential adverse events being monitored?
title_short Patients in chronic prednisone use in a Brazilian municipality: are potential adverse events being monitored?
title_full Patients in chronic prednisone use in a Brazilian municipality: are potential adverse events being monitored?
title_fullStr Patients in chronic prednisone use in a Brazilian municipality: are potential adverse events being monitored?
title_full_unstemmed Patients in chronic prednisone use in a Brazilian municipality: are potential adverse events being monitored?
title_sort patients in chronic prednisone use in a brazilian municipality: are potential adverse events being monitored?
publisher Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
publishDate 2020
url https://doaj.org/article/71de3191bf954d0894f974a752565640
work_keys_str_mv AT virginiambolina patientsinchronicprednisoneuseinabrazilianmunicipalityarepotentialadverseeventsbeingmonitored
AT thayssmendonca patientsinchronicprednisoneuseinabrazilianmunicipalityarepotentialadverseeventsbeingmonitored
AT marianalpereira patientsinchronicprednisoneuseinabrazilianmunicipalityarepotentialadverseeventsbeingmonitored
AT carolinepdomingueti patientsinchronicprednisoneuseinabrazilianmunicipalityarepotentialadverseeventsbeingmonitored
AT joaoprodrigues patientsinchronicprednisoneuseinabrazilianmunicipalityarepotentialadverseeventsbeingmonitored
AT tiagomreis patientsinchronicprednisoneuseinabrazilianmunicipalityarepotentialadverseeventsbeingmonitored
AT andreoliveirabaldoni patientsinchronicprednisoneuseinabrazilianmunicipalityarepotentialadverseeventsbeingmonitored
_version_ 1718408445083779072